![BM Rhus Tox 1 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 7 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/g Ointment, 40 g — NDC 85816-6023-01 package photo](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3890f0d6-0f02-2266-e063-6394a90ae2bc&name=Rhus+Tox+Ointment+Box.jpg)
BM Rhus Tox 1 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 7 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/g Ointment, 40 g
by BM Private Limited · 40 g in 1 JAR (85816-6023-1)
NDC 85816-6023-01
🏷️ FDA NDC (as labeled)
85816-6023-1
billing pads the package segment with a zero
This package
Contains40 g
Pack sizes2 compare ↓
Also comes in:
40 g 85816-6023-02
OTC
On market
Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
85816-6023-1
Product NDC
85816-6023
11-digit billing NDC
85816602301
UNII
5S29HWU6QB, O80TY208ZW, 2HU33I03UY, T7J046YI2B, N20HL7Q941, 856YO1Z64F +2 more
SPL Set ID
3890f0d6-0f02-2266-e063-6394a90ae2bc
Established class (EPC)
Non-Standardized Food Allergenic Extract
Physiologic effect
Increased Histamine Release; Cell-mediated Immunity
Chemical class
Dietary Proteins; Food Additives; Allergens
DEA schedule
Non-controlled
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2015-01-01
Route
TOPICAL
Dosage form
OINTMENT
Substance
CINNAMON; ARNICA MONTANA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CAMPHOR (NATURAL); TURMERIC; COLCHICUM AUTUMNALE BULB; TOXICODENDRON PUBESCENS LEAF
Why two NDCs?
The FDA registers this code as 85816-6023-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 85816-6023-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerBM Private Limited
Labeler code85816
First marketedJan 2015
Product typeHuman Otc Drug
Portfolio211 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
🧪 What is this product?
BM Rhus Tox is a topical ointment containing multiple plant-based ingredients used in homeopathic practice. The formula includes arnica montana, bellis perennis, bryonia alba, turmeric, and toxicodendron pubescens, among others, along with natural camphor and cinnamon. These ingredients are traditionally used in homeopathy for minor joint and muscle discomfort. This is an unapproved homeopathic product marketed based on homeopathic tradition rather than FDA-evaluated clinical evidence of effectiveness.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Rhus Tox?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
yellow
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
0.095 g / 1 g
UNII 2DMT128M1S
A waxy solid derived from plant or animal sources. It acts as an emulsifier to blend oil and water components, and also thickens the medicine to give it the right texture and consistency.
-
0.04 g / 1 g
UNII T5L8T28FGP
Mineral oil is a clear, odorless liquid derived from crude oil. It acts as a lubricant and emollient in medications, helping pills slide smoothly during manufacturing and aiding moisture retention in topical products.
-
0.865 g / 1 g
UNII B6E5W8RQJ4
White petrolatum is a purified mineral oil product used as a lubricant and skin protectant in medications. It helps pills slide through manufacturing equipment and can soften or protect the skin when applied topically.
3 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesInactive Ingredients: Cetostearyl alcohol, Paraffin oil, White soft paraffin
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
40 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| BM Rhus Tox 1 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 7 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/gthis 85816-6023-01 | BM | 40 g | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2015
On the market since
Jan 2015
📍
2026
Currently FDA-listed
11 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Rhus Tox — the ingredient across all brands.
Top reported reactions
Reporter sex
Male · 32%
Female · 68%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 85816-6023-01 You're viewing this | 40 g in 1 JAR (85816-6023-1) | 2015-01-01 | Active |
| 85816-6023-02 | 40 g in 1 TUBE (85816-6023-2) | 2025-10-10 | Active |
Pack size FAQ
What quantity is in NDC 85816-6023-01?
NDC 85816-6023-01 contains 40 g — 40 g in 1 jar.
What is the difference between NDC 85816-6023-01 and NDC 85816-6023-02?
Both are BM Rhus Tox 1 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 7 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/g Ointment — the drug itself is identical. NDC 85816-6023-01 is the 40 g package, while NDC 85816-6023-02 is the 40 g package.
What NDC number is used to bill for this package of BM Rhus Tox 1 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 7 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/g Ointment?
Bill NDC 85816-6023-01 — the 11-digit billing format is 85816602301. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
Homeopathic listing
About homeopathic listings
BM Rhus Tox 1 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 7 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/g OINTMENT is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 85816-6023-1, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 85816-6023-01, written without dashes as 85816602301. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 85816-6023-01, the first segment (85816) is the labeler code FDA assigned to BM Private Limited; the middle segment (6023) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by BM Private Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 40 g (85816-6023-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
BM Private Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses* Helps temporarily relieve: joint and muscle aches; stiffness; swelling; discomfort; soreness
⏱️ Dosage and Administration ▾
Directions: Use as directed. Clean the affected area before application. Apply a thin layer to the affected area, 2-3 times daily or as directed by a physician.
⚠️ Warnings ▾
Warnings: For external use only. Avoid contact with eyes and mucous membranes. Keep out of reach of children. If you have severe symptoms, consult a doctor before use. Do not use on broken or damaged skin.
📦 Storage and Handling ▾
Storage: Store in a cool, dry place below 30°C (86°F). Protect from direct sunlight.
🧪 Active Ingredient ▾
Active ingredients Arnica mont Ø (HPUS) Bellis per Ø (HPUS) Bryonia alb D7 (EHPI) Camphora Ø (HPUS) Cinnamomum Ø (HPUS) Colchicum D6 (HPUS) Curcuma longa Ø (GHP) Rhus toxicodendron D6 Ø (HPUS)
🧪 Inactive Ingredients ▾
Inactive Ingredients: Cetostearyl alcohol, Paraffin oil, White soft paraffin
🎯 Purpose ▾
Active ingredients Purpose* Arnica mont Ø (HPUS).................joint pain Bellis per Ø (HPUS)....................soreness & stiffness Bryonia alb D7 (EHPI)...............joint discomfort Camphora Ø (HPUS).................soreness Cinnamomum Ø (HPUS)...........poor circulation Colchicum D6 (HPUS).............stiffness Curcuma longa Ø (GHP)...........pain & swelling Rhus toxicodendron D6 (HPUS).. stiffness and joint & muscle pain
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.